Widespread genomic influences on phenotype in Dravet syndrome, a ‘monogenic’ condition
Open accessThe DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Abstract
Dravet syndrome is an archetypal rare severe epilepsy, considered ‘monogenic’, typically caused by loss-of-function SCN1A variants. Despite a recognizable core phenotype, its marked phenotypic heterogeneity is incompletely explained by differences in the causal SCN1A variant or clinical factors. In 34 adults with SCN1A-related Dravet syndrome, we show additional genomic variation beyond SCN1A contributes to phenotype and its diversity, with an excess of rare variants in epilepsy-related genes as a set and examples of blended phenotypes, including one individual with an ultra-rare DEPDC5 variant and focal cortical dysplasia. The polygenic risk score for intelligence was lower, and for longevity, higher, in Dravet syndrome than in epilepsy controls. The causal, major-effect, SCN1A variant may need to act against a broadly compromised genomic background to generate the full Dravet syndrome phenotype, whilst genomic resilience may help to ameliorate the risk of premature mortality in adult Dravet syndrome survivors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 FCD and details of DEPDC5 variant. (A) Brain MRI showing FCD. Coronal T1-weighted brain MRI from Case 1-102398, with DEPDC5 variant NM_001242896.3:c.G4183A:p.A1395T, showing left temporal lobe FCD (right of patient is on the left of the image, following radiological convention), with blurred grey–white interface and cortical thickening apparent in the left temporal lobe across several consecutive slices. (B) MetaDome map of regional constraint in DEPDC5. Grey bar below the graph represents the protein, pink bars showing Pfam domains: PF12257, Vacuolar membrane-associated protein Iml1 domain; PF00610, Domain found in Dishevelled, Egl-10, and Pleckstrin (DEP); A1395 is marked by a vertical green line, with a reported tolerance score of 0.28 (‘intolerant’). (C) VarSite sequence logo for DEPDC5 residues 1375–1414, based on alignment of structural homologues; below the logo is the sequence of DEPDC5 itself, with A1395 boxed; sequence conservation score for this residue was 0.92 [range 0 (low)–1 (high)]; alanine was observed at this position in 31/33 aligned sequences. (D) Structure of the GATOR1-Rag GTPases complex and context of DEPDC5 Ala1395. PDB 6ces, the structure of the heterotrimeric GATOR1 complex (DEPDC5:NPRL2:NPRL3) bound to RagA and RagC GTPases; protein surfaces shown by colour as indicated (except DEPDC5, shown as a ribbon and coloured by structural domains as annotated by Shen et al.39: bright green = N-terminal domain (NTD) (residues 38–165); cyan = SABA domain (166–425); orange = steric hindrance for enhancement of nucleotidase activity (SHEN) domain (721–1010); dark green = DEP domain (1175–1270); violet = C-terminal domain (CTD) (1271–1600); Ala1395 is pink with sidechain atoms shown as spheres. (E and F) Ala1395 lies at an inter-domain interface in DEPDC5. The figure shows selected residues of DEPDC5 from PDB 6ces (chain D); residues of the NTD, SABA domain and CTD are shown as separate surfaces; residues of the SHEN domain and DEP domain are shown as ribbons. F shows the same structure as E with SHEN and DEP domains removed; residues Tyr108 (bright green), Phe326 (blue) and Ala1395 (rose pink) lie in close proximity at a three-way interface between the NTD, SABA and CTD. (G) Enlarged image of the DEPDC5 structure (PDB 6ces, chain D) as in E and F, zoomed to show detail around the three-way interface between the NTD, SABA and CTD; (H) The Ala1395Thr substitution results in reduced space at the inter-domain interface in 6cesD. This figure shows the same structure as G after introduction of the Ala1395Thr variant by in silico mutagenesis. Quantitative results are given in Supplementary material 18. Analysis of DEPDC5 from PDB 6cet is shown in Supplementary Fig. 1](https://figures.cochat.ai/paper-figures/be7850fa03d9424fada62405cbff8754/widespread-genomic-influences-on-phenotype-in-dravet-syndrome-a-monogenic-figure-3.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is also unclear whether differences in severity of cognitive impairment among family members with the same SCN1A pathogenic variant, where one individual has Dravet syndrome and another has GEFS+, is due to genomic background, environmental factors or more severe seizures in the individual with Dravet syndrome 244 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [244]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Already, techniques are emerging, such as polygenic risk scores, that aid in understanding the interaction of rare and common variation in determining phenotypic variability 244,246 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [244]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
The Ensembl Variant Effect Predictor
McLaren, W., Gil, L., Hunt, S. E., Riat, H. S., Ritchie, G. R. S., Thormann, A., Flicek, P., & Cunningham, F. (2016) · Genome Biology · doi:10.1186/s13059-016-0974-4 · Cited by 8,099
An atlas of genetic correlations across human diseases and traits
ReproGen Consortium, Bulik-Sullivan, B., Psychiatric Genomics Consortium, Genetic Consortium for Anorexia Nervosa of the Wellcome Trust Case Control Consortium 3, Finucane, H. K., Anttila, V., Gusev, A., Day, F. R., Loh, P.-R., Duncan, L., et al. (2015) · Nature Genetics · doi:10.1038/ng.3406 · Cited by 4,255
Tutorial: a guide to performing polygenic risk score analyses
Choi, S. W., Mak, T. S.-H., & O’Reilly, P. F. (2020) · Nature Protocols · doi:10.1038/s41596-020-0353-1 · Cited by 1,946
PRSice-2: Polygenic Risk Score software for biobank-scale data
Choi, S. W., & O'Reilly, P. F. (2019) · GigaScience · doi:10.1093/gigascience/giz082 · Cited by 1,532
Distribution and intensity of constraint in mammalian genomic sequence
Cooper, G. M., Stone, E. A., Asimenos, G., Green, E. D., Batzoglou, S., & Sidow, A. (2005) · Genome Research · doi:10.1101/gr.3577405 · Cited by 1,359
Savage, J. E., Jansen, P. R., Stringer, S., Watanabe, K., Bryois, J., de Leeuw, C. A., Nagel, M., Awasthi, S., Barr, P. B., Coleman, J. R. I., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0152-6 · Cited by 1,267
Self-citationLee, S., Emond, M. J., Bamshad, M. J., Barnes, K. C., Rieder, M. J., Nickerson, D. A., Christiani, D. C., Wurfel, M. M., & Lin, X. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.06.007 · Cited by 1,066
Zuberi, S. M., Wirrell, E., Yozawitz, E., Wilmshurst, J. M., Specchio, N., Riney, K., Pressler, R., Auvin, S., Samia, P., Hirsch, E., et al. (2022) · Epilepsia · doi:10.1111/epi.17239 · Cited by 934
Self-citationResolution of Disease Phenotypes Resulting from Multilocus Genomic Variation
Posey, J. E., Harel, T., Liu, P., Rosenfeld, J. A., James, R. A., Coban Akdemir, Z. H., Walkiewicz, M., Bi, W., Xiao, R., Ding, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1516767 · Cited by 769
Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteria
Nykamp, K., Anderson, M., Powers, M., Garcia, J., Herrera, B., Ho, Y.-Y., Kobayashi, Y., Patil, N., Thusberg, J., Westbrook, M., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.37 · Cited by 762
100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report
The 100, 0. G. P. P. I. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035790 · Cited by 716
Identification of Genetic Factors that Modify Clinical Onset of Huntington’s Disease
Lee, J.-M., Wheeler, V. C., Chao, M. J., Vonsattel, J. P. G., Pinto, R. M., Lucente, D., Abu-Elneel, K., Ramos, E. M., Mysore, J. S., Gillis, T., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.003 · Cited by 655
Self-citationThe genetic landscape of the epileptic encephalopathies of infancy and childhood
McTague, A., Howell, K. B., Cross, J. H., Kurian, M. A., & Scheffer, I. E. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00250-1 · Cited by 604
Self-citationPanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels
Martin, A. R., Williams, E., Foulger, R. E., Leigh, S., Daugherty, L. C., Niblock, O., Leong, I. U. S., Smith, K. R., Gerasimenko, O., Haraldsdottir, E., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0528-2 · Cited by 559 · cited 5×
“To evaluate if individuals with Dravet syndrome harbour a higher burden of additional rare variants compared to the control cohorts, we performed gene-based and gene-set collapsing analyses for rare variants across 190 epilepsy-related genes, excluding SCN1A.13,15 Each gene was considered individually for the genebase…”
InfluentialSelf-citationThe spectrum of SCN1A-related infantile epileptic encephalopathies
Harkin, L. A., McMahon, J. M., Iona, X., Dibbens, L., Pelekanos, J. T., Zuberi, S. M., Sadleir, L. G., Andermann, E., Gill, D., Farrell, K., et al. (2007) · Brain · doi:10.1093/brain/awm002 · Cited by 531
Self-citationThe International League Against Epilepsy Consortium on Complex Epilepsies, Abou-Khalil, B., Auce, P., Avbersek, A., Bahlo, M., Balding, D. J., Bast, T., Baum, L., Becker, A. J., Becker, F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07524-z · Cited by 482
Self-citationSymonds, J. D., Zuberi, S. M., Stewart, K., McLellan, A., O‘Regan, M., MacLeod, S., Jollands, A., Joss, S., Kirkpatrick, M., Brunklaus, A., et al. (2019) · Brain · doi:10.1093/brain/awz195 · Cited by 459
Self-citationPolygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions
Fahed, A. C., Wang, M., Homburger, J. R., Patel, A. P., Bick, A. G., Neben, C. L., Lai, C., Brockman, D., Philippakis, A., Ellinor, P. T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17374-3 · Cited by 455
Mutations in DEPDC5 cause familial focal epilepsy with variable foci
Dibbens, L. M., de Vries, B., Donatello, S., Heron, S. E., Hodgson, B. L., Chintawar, S., Crompton, D. E., Hughes, J. N., Bellows, S. T., Klein, K. M., et al. (2013) · Nature Genetics · doi:10.1038/ng.2599 · Cited by 373
Self-citationA meta-analysis of genome-wide association studies identifies multiple longevity genes
Deelen, J., Evans, D. S., Arking, D. E., Tesi, N., Nygaard, M., Liu, X., Wojczynski, M. K., Biggs, M. L., van der Spek, A., Atzmon, G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11558-2 · Cited by 370
Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome
Brunklaus, A., Ellis, R., Reavey, E., Forbes, G. H., & Zuberi, S. M. (2012) · Brain · doi:10.1093/brain/aws151 · Cited by 366 · cited 1×
“The variant distribution is comparable to published cohorts of individuals with SCN1A-related syndromes.(4,29,30) No obvious association between variant class (i.”
Self-citationDissecting the genetic basis of focal cortical dysplasia: a large cohort study
Baldassari, S., Ribierre, T., Marsan, E., Adle-Biassette, H., Ferrand-Sorbets, S., Bulteau, C., Dorison, N., Fohlen, M., Polivka, M., Weckhuysen, S., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02061-5 · Cited by 356
Self-citationMulley, J. C., Scheffer, I. E., Petrou, S., Dibbens, L. M., Berkovic, S. F., & Harkin, L. A. (2005) · Human Mutation · doi:10.1002/humu.20178 · Cited by 351
Self-citationHan, Z., Chen, C., Christiansen, A., Ji, S., Lin, Q., Anumonwo, C., Liu, C., Leiser, S. C., Meena, Aznarez, I., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz6100 · Cited by 341
Kuchenbaecker, K. B., McGuffog, L., Barrowdale, D., Lee, A., Soucy, P., Dennis, J., Domchek, S. M., Robson, M., Spurdle, A. B., Ramus, S. J., et al. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw302 · Cited by 327
Self-citation100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report.
Smedley, D. P., Smedley, D. P., Smith, K. R., Martin, A., Thomas, E. A., McDonagh, E. M., Cipriani, V., Ellingford, J. M., Arno, G., Tucci, A., et al. (2021) · UCL Discovery (University College London) · doi:10.17863/cam.108059 · Cited by 318
Self-citationCooper, M. S., Mcintosh, A., Crompton, D. E., McMahon, J. M., Schneider, A., Farrell, K., Ganesan, V., Gill, D., Kivity, S., Lerman-Sagie, T., et al. (2016) · Epilepsy Research · doi:10.1016/j.eplepsyres.2016.10.006 · Cited by 316
Self-citationMoss, D. J. H., Pardiñas, A. F., Langbehn, D., Lo, K., Leavitt, B. R., Roos, R., Durr, A., Mead, S., Coleman, A., Santos, R. D., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30161-8 · Cited by 312 · cited 1×
“etic contributor of a genetic condition can allow additional genetic contributions to the phenotype to be discovered, as has been shown for example in Huntington’s disease.(72,73) Here, we adopted the same approach to Dravet syndrome, exploring WGS from a small group of adults with Dravet syndrome due to variation in…”
MethodWolff, M., Cassé‐Perrot, C., & Dravet, C. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00688.x · Cited by 308
Lindy, A. S., Stosser, M. B., Butler, E., Downtain‐Pickersgill, C., Shanmugham, A., Retterer, K., Brandt, T., Richard, G., & McKnight, D. A. (2018) · Epilepsia · doi:10.1111/epi.14074 · Cited by 305
Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals
Feng, Y.-C. A., Howrigan, D. P., Abbott, L. E., Tashman, K., Cerrato, F., Singh, T., Heyne, H., Byrnes, A., Churchhouse, C., Watts, N., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.05.020 · Cited by 297
Self-citationFamilial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations
Baulac, S., Ishida, S., Marsan, E., Miquel, C., Biraben, A., Nguyen, D. K., Nordli, D., Cossette, P., Nguyen, S., Lambrecq, V., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24368 · Cited by 293
D'Gama, A. M., Geng, Y., Couto, J. A., Martin, B., Boyle, E. A., LaCoursiere, C. M., Hossain, A., Hatem, N. E., Barry, B. J., Kwiatkowski, D. J., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24357 · Cited by 290
Genotype–phenotype associations in SCN1A -related epilepsies
Zuberi, S. M., Brunklaus, A., Birch, R., Reavey, E., Duncan, J., & Forbes, G. H. (2011) · Neurology · doi:10.1212/wnl.0b013e31820c309b · Cited by 252
Self-citationSCN1A‐related phenotypes: Epilepsy and beyond
Scheffer, I. E., & Nabbout, R. (2019) · Epilepsia · doi:10.1111/epi.16386 · Cited by 245 · cited 2×
“do not obviously fit these categories but may share some core features, such as fever-provoked seizures.(5) Further, people with pathogenic var-”
BackgroundSelf-citationThe landscape of epilepsy-related GATOR1 variants
Baldassari, S., Picard, F., Verbeek, N. E., van Kempen, M., Brilstra, E. H., Lesca, G., Conti, V., Guerrini, R., Bisulli, F., Licchetta, L., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0060-2 · Cited by 240
Self-citationScheffer, I. E., Heron, S. E., Regan, B. M., Mandelstam, S., Crompton, D. E., Hodgson, B. L., Licchetta, L., Provini, F., Bisulli, F., Vadlamudi, L., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24126 · Cited by 229
Self-citationEncephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy
Nabbout, R., Chemaly, N., Chipaux, M., Barcia, G., Bouis, C., Dubouch, C., Leunen, D., Jambaqué, I., Dulac, O., Dellatolas, G., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-176 · Cited by 197
Architecture of the human GATOR1 and GATOR1–Rag GTPases complexes
Shen, K., Huang, R. K., Brignole, E. J., Condon, K. J., Valenstein, M. L., Chantranupong, L., Bomaliyamu, A., Choe, A., Hong, C., Yu, Z., et al. (2018) · Nature · doi:10.1038/nature26158 · Cited by 192 · cited 3×
“et al.(39)), in close proximity to residues within those domains (Fig.”
InfluentialMapping genetic modifiers of survival in a mouse model of Dravet syndrome
Miller, A. R., Hawkins, N. A., McCollom, C. E., & Kearney, J. A. (2014) · Genes, Brain and Behavior · doi:10.1111/gbb.12099 · Cited by 188
Iranome: A catalog of genomic variations in the Iranian population
Fattahi, Z., Beheshtian, M., Mohseni, M., Poustchi, H., Sellars, E., Nezhadi, S. H., Amini, A., Arzhangi, S., Jalalvand, K., Jamali, P., et al. (2019) · Human Mutation · doi:10.1002/humu.23880 · Cited by 185
Mortality in Dravet syndrome: A review
Shmuely, S., Sisodiya, S. M., Gunning, W. B., Sander, J. W., & Thijs, R. D. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.09.007 · Cited by 184
Self-citationde Lange, I. M., Gunning, B., Sonsma, A. C. M., van Gemert, L., van Kempen, M., Verbeek, N. E., Nicolai, J., Knoers, N. V. A. M., Koeleman, B. P. C., & Brilstra, E. H. (2018) · Epilepsia · doi:10.1111/epi.14191 · Cited by 161
Self-citationSevere myoclonic epilepsy of infancy (Dravet syndrome): Recognition and diagnosis in adults
Jansen, F. E., Sadleir, L. G., Harkin, L. A., Vadlamudi, L., McMahon, J. M., Mulley, J. C., Scheffer, I. E., & Berkovic, S. F. (2006) · Neurology · doi:10.1212/01.wnl.0000249312.73155.7d · Cited by 157
Self-citationFocal Cortical Dysplasia: Gene Mutations, Cell Signaling, and Therapeutic Implications
Iffland, P. H., & Crino, P. B. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100138 · Cited by 142
Genetic epilepsy with febrile seizures plus: Refining the spectrum
Zhang, Y.-H., Burgess, R., Malone, J. P., Glubb, G. C., Helbig, K. L., Vadlamudi, L., Kivity, S., Afawi, Z., Bleasel, A., Grattan-Smith, P., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004384 · Cited by 139
Self-citationCognitive development in Dravet syndrome: A retrospective, multicenter study of 26 patients
Ragona, F., Granata, T., Bernardina, B. D., Offredi, F., Darra, F., Battaglia, D., Morbi, M., Brazzo, D., Cappelletti, S., Chieffo, D., et al. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02925.x · Cited by 137
Self-citationYamagata, T., Raveau, M., Kobayashi, K., Miyamoto, H., Tatsukawa, T., Ogiwara, I., Itohara, S., Hensch, T. K., & Yamakawa, K. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104954 · Cited by 136
Tanenhaus, A., Stowe, T., Young, A., McLaughlin, J., Aeran, R., Lin, I. W., Li, J., Hosur, R., Chen, M., Leedy, J., et al. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.037 · Cited by 124
Defining Dravet syndrome: An essential pre‐requisite for precision medicine trials
Li, W., Schneider, A. L., & Scheffer, I. E. (2021) · Epilepsia · doi:10.1111/epi.17015 · Cited by 123
Self-citationCo‐occurring malformations of cortical development and SCN 1A gene mutations
Barba, C., Parrini, E., Coras, R., Galuppi, A., Craiu, D., Kluger, G., Parmeggiani, A., Pieper, T., Schmitt‐Mechelke, T., Striano, P., et al. (2014) · Epilepsia · doi:10.1111/epi.12658 · Cited by 98
Self-citationMay, P., Girard, S., Harrer, M., Bobbili, D. R., Schubert, J., Wolking, S., Becker, F., Lachance‐Touchette, P., Meloche, C., Gravel, M., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30215-1 · Cited by 95
Self-citationBrain MRI Findings in Severe Myoclonic Epilepsy in Infancy and Genotype–Phenotype Correlations
Striano, P., Mancardi, M. M., Biancheri, R., Madia, F., Gennaro, E., Paravidino, R., Beccaria, F., Capovilla, G., Bernardina, B. D., Darra, F., et al. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01020.x · Cited by 91
Self-citationUK Biobank Whole-Exome Sequence Binary Phenome Analysis with Robust Region-Based Rare-Variant Test
Zhao, Z., Bi, W., Zhou, W., VandeHaar, P., Fritsche, L. G., & Lee, S. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.11.012 · Cited by 83
Epileptic spasms are a feature of DEPDC5 mTORopathy
Carvill, G. L., Crompton, D. E., Regan, B. M., McMahon, J. M., Saykally, J., Zemel, M., Schneider, A. L., Dibbens, L., Howell, K. B., Mandelstam, S., et al. (2015) · Neurology Genetics · doi:10.1212/nxg.0000000000000016 · Cited by 76
Self-citationVariable epilepsy phenotypes associated with a familial intragenic deletion of the SCN1A gene
Guerrini, R., Cellini, E., Mei, D., Metitieri, T. T., Petrelli, C., Pucatti, D., Marini, C., & Zamponi, N. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02790.x · Cited by 68
Self-citationde Lange, I. M., Koudijs, M. J., van 't Slot, R., Gunning, B., Sonsma, A. C. M., van Gemert, L. J. J. M., Mulder, F., Carbo, E. C., van Kempen, M. J. A., Verbeek, N. E., et al. (2018) · Epilepsia · doi:10.1111/epi.14021 · Cited by 64
Self-citationFast and robust ancestry prediction using principal component analysis
Zhang, D., Dey, R., & Lee, S. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa152 · Cited by 63
Brain Organoids as Model Systems for Genetic Neurodevelopmental Disorders
Baldassari, S., Musante, I., Iacomino, M., Zara, F., Salpietro, V., & Scudieri, P. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.590119 · Cited by 62
Self-citationNeuroimaging and neuropathology of Dravet syndrome
Guerrini, R., Striano, P., Catarino, C., & Sisodiya, S. M. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.02998.x · Cited by 60
Self-citationOutcomes and comorbidities of SCN1A-related seizure disorders
Lange, I., Gunning, B. W., Sonsma, A. C. M., van Gemert, L., van Kempen, M. J. A., Verbeek, N. E., Sinoo, C., Nicolai, J., Knoers, N. V. A. M., Koeleman, B. P. C., et al. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.09.041 · Cited by 56
Self-citationGenetic Determinants of Sudden Unexpected Death in Pediatrics
Koh, H. Y., Haghighi, A., Keywan, C., Alexandrescu, S., Plews-Ogan, E., Haas, E. A., Brownstein, C. A., Vargas, S. O., Haynes, R. L., Berry, G. T., et al. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2021.12.004 · Cited by 50
The role of common genetic variation in presumed monogenic epilepsies
Campbell, C., Leu, C., Feng, Y.-C. A., Wolking, S., Moreau, C., Ellis, C., Ganesan, S., Martins, H., Oliver, K., Boothman, I., et al. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104098 · Cited by 42 · cited 2×
“However, evidence shows that the polygenic background may have a more substantial and clinically relevant effect in individuals with a monogenic disease,75,76 demonstrating the principle that the rest of the genome is not inert in monogenic epilepsies, as recently demonstrated in unselected DEEs.77 For example, in two…”
BackgroundSelf-citationFocal epilepsy in SCN1A ‐mutation carrying patients: is there a role for epilepsy surgery?
Vezyroglou, A., Varadkar, S., Bast, T., Hirsch, É., Strobl, K., Harvey, A. S., Epilepsy Surgery in SCN1A Study Group, Scheffer, I. E., Sisodiya, S. M., & Cross, J. H. (2020) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14588 · Cited by 36
Self-citationBrunklaus, A., Ellis, R., Stewart, H. S., Aylett, S., Reavey, E., Jefferson, R., Jain, R., Chakraborty, S., Jayawant, S., & Zuberi, S. M. (2015) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2015.02.001 · Cited by 32
Self-citationBuoni, S., Orrico, A., Galli, L., Zannolli, R., Burroni, L., Hayek, J., Fois, A., & Sorrentino, V. (2006) · Neurology · doi:10.1212/01.wnl.0000198504.41315.b1 · Cited by 32
Modifier genes in SCN1A ‐related epilepsy syndromes
Lange, I., Mulder, F., Slot, R. V. ‘., Sonsma, A. C. M., van Kempen, M. J. A., Nijman, I. J., Ernst, R. F., Knoers, N. V. A. M., Brilstra, E. H., & Koeleman, B. P. C. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1103 · Cited by 30
Self-citationStaněk, D., Laššuthová, P., Štěrbová, K., Vlčková, M., Neupauerová, J., Krůtová, M., & Seeman, P. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0812-8 · Cited by 28
Hammer, M. F., Ishii, A., Johnstone, L. M., Tchourbanov, A. Y., Lau, B., Sprissler, R. S., Hallmark, B., Zhang, M., Zhou, J. J., Watkins, J. C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180485 · Cited by 27
Novel variants in SPTAN1 without epilepsy: An expansion of the phenotype
Gartner, V., Markello, T. C., Macnamara, E. F., Biase, A. D., Thurm, A. E., Joseph, L. A., Beggs, A. H., Schmahmann, J. D., Berry, G. T., Anselm, I. A., et al. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.40628 · Cited by 26
Gorman, K. M., Peters, C. H., Lynch, B., Jones, L., Bassett, D. S., King, M. D., Ruben, P. C., & Rosch, R. E. (2021) · Brain Communications · doi:10.1093/braincomms/fcab235 · Cited by 22
Self-citationGertler, T. S., Calhoun, J. D., & Laux, L. (2019) · Seizure · doi:10.1016/j.seizure.2019.12.009 · Cited by 21
Late diagnoses of Dravet syndrome: How many individuals are we missing?
Silvennoinen, K., Puvirajasinghe, C., Hudgell, K., Sidhu, M., Custodio, H. M., Jones, W., Balestrini, S., Sisodiya, S., Ambrose, J., Arumugam, P., et al. (2021) · Epilepsia Open · doi:10.1002/epi4.12525 · Cited by 19
Self-citationInfluence of common SCN1A promoter variants on the severity of SCN1A‐related phenotypes
Lange, I., Weuring, W. J., Slot, R. V. ‘., Gunning, B. W., Sonsma, A. C. M., McCormack, M., de Kovel, C. G. F., van Gemert, L. J. J. M., Mulder, F., van Kempen, M. J. A., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.727 · Cited by 17
Self-citationMutation spectrum of the SCN1A gene in a Hungarian population with epilepsy
Till, Á., Zima, J., Fekete, A., Bene, J., Czakó, M., Szabó, A., Melegh, B., & Hadzsiev, K. (2019) · Seizure · doi:10.1016/j.seizure.2019.10.019 · Cited by 17
Dravet syndrome associated with cortical dysplasia of Taylor-type
Wright, R., Hernandez, A. W., Malik, S. I., Donahue, D., Alles, A. J., & Perry, M. S. (2015) · Journal of Pediatric Neurology · doi:10.3233/jpn-2011-0508 · Cited by 3
Cited by
Developmental and epileptic encephalopathies
Scheffer, I. E., Zuberi, S., Mefford, H. C., Guerrini, R., & McTague, A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00546-6 · Cited by 158
Self-citationGuidance for estimating penetrance of monogenic disease-causing variants in population cohorts
Wright, C. F., Sharp, L. N., Jackson, L. M., Murray, A., Ware, J. S., MacArthur, D. G., Rehm, H. L., Patel, K., & Weedon, M. N. (2024) · Nature Genetics · doi:10.1038/s41588-024-01842-3 · Cited by 60
Genotype–phenotype associations in 1018 individuals with SCN1A‐related epilepsies
Gallagher, D., Pérez‐Palma, E., Brünger, T., Ghanty, I., Brilstra, E. H., Ceulemans, B., Chémaly, N., Lange, I., Depienne, C., Guerrini, R., et al. (2024) · Epilepsia · doi:10.1111/epi.17882 · Cited by 48
Self-citationZebrafish: unraveling genetic complexity through duplicated genes
Tasnim, M., Wahlquist, P., & Hill, J. T. (2024) · Development Genes and Evolution · doi:10.1007/s00427-024-00720-6 · Cited by 41
Heyne, H., Pajuste, F., Wanner, J., Onwuchekwa, J. I. D., Mägi, R., Palotie, A. V., FinnGen, Kälviäinen, R. K., & Daly, M. J. (2024) · Nature Communications · doi:10.1038/s41467-024-50295-z · Cited by 35
Metadata
- Authors
- Martins Custodio, H., Clayton, L. M., Bellampalli, R., Pagni, S., Silvennoinen, K., Caswell, R., Genomics England Research Consortium, Ambrose, J. C., Arumugam, P., Bevers, R., Bleda, M., Boardman-Pretty, F., Boustred, C. R., Brittain, H., Brown, M. A., Caulfield, M. J., Chan, G. C., Giess, A., Griffin, J. N., Hamblin, A., Henderson, S., Hubbard, T. J. P., Jackson, R., Jones, L. J., Kasperaviciute, D., Kayikci, M., Kousathanas, A., Lahnstein, L., Lakey, A., Leigh, S. E. A., Leong, I. U. S., Lopez, J. F., Maleady-Crowe, F., McEntagart, M., Minneci, F., Mitchell, J., Moutsianas, L., Mueller, M., Murugaesu, N., Need, A. C., O'Donovan, P., Odhams, C. A., Patch, C., Perez-Gil, D., Pereira, M. B., Pullinger, J., Rahim, T., Rendon, A., Rogers, T., Savage, K., Sawant, K., Scott, R. H., Siddiq, A., Sieghart, A., Smith, S. C., Sosinsky, A., Stuckey, A., Tanguy, M., Tavares, A. L. T., Thomas, E. R. A., Thompson, S. R., Tucci, A., Welland, M. J., Williams, E., Witkowska, K., Wood, S. M., Zarowiecki, M., Brunklaus, A., Guerrini, R., Koeleman, B. P. C., Lemke, J. R., Møller, R. S., Scheffer, I. E., Weckhuysen, S., Zara, F., Zuberi, S., Kuchenbaecker, K., Balestrini, S., Mills, J. D., & Sisodiya, S. M.
- Affiliations
- University College London Queen Square Institute of Neurology, Department of Clinical and Experimental Epilepsy , London, WC1N 3BG , UK
- UCL Queen Square Institute of Neurology (GB)
- Kuopio University Hospital (FI)
- Royal Devon University Healthcare NHS Foundation Trust (GB)
- Istituto Giannina Gaslini (IT)
- Royal Hospital for Children (GB)
- Meyer Children's Hospital (IT)
- University Medical Center Utrecht (NL)
- University Hospital Leipzig (DE)
- University of Southern Denmark (DK)
- Royal Children's Hospital (AU)
- University of Antwerp (BE)
- University College London (GB)
- Amsterdam Neuroscience (NL)
- Corresponding author
- Sisodiya, Sanjay M
- ORCID
- Clayton, Lisa M
- Bellampalli, Ravishankara
- Silvennoinen, Katri
- Caswell, Richard
- Arumugam, Prabhu
- Bevers, Roel
- Bleda, Marta
- Boustred, Christopher R
- Brittain, Helen
- Brown, Matthew A
- Caulfield, Mark J
- Giess, Adam
- Griffin, John N
- Hamblin, Angela
- Kayikci, Melis
- Kousathanas, Athanasios
- Leigh, Sarah E A
- McEntagart, Meriel
- Mitchell, Jonathan
- Moutsianas, Loukas
- Murugaesu, Nirupa
- Need, Anna C
- Patch, Christine
- Pullinger, John
- Rahim, Tahrima
- Rendon, Augusto
- Scott, Richard H
- Siddiq, Afshan
- Sieghart, Alexander
- Sosinsky, Alona
- Stuckey, Alexander
- Tanguy, Mélanie
- Tavares, Ana Lisa Taylor
- Thompson, Simon R
- Tucci, Arianna
- Welland, Matthew J
- Williams, Eleanor
- Witkowska, Katarzyna
- Zarowiecki, Magdalena
- Brunklaus, Andreas
- Guerrini, Renzo
- Koeleman, Bobby P C
- Lemke, Johannes R
- Møller, Rikke S
- Scheffer, Ingrid E
- Weckhuysen, Sarah
- Zara, Federico
- Zuberi, Sameer
- Kuchenbaecker, Karoline
- Balestrini, Simona
- Mills, James D
- Sisodiya, Sanjay M
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-04-03
- Volume
- 146
- Issue
- 9
- Pages
- 3885-3897
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC10473570
- OpenAlex
- W4362505742
- Cited by
- 62
- References
- 78
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 19 · 2023: 7
- FWCI
- 12.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, public-domain)
- UCL Discovery (University College London) (submittedVersion, cc-by)
- Florence Research (University of Florence) (submittedVersion, public-domain)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion, other-oa)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, cc-by)
- Funders
- Wellcome Trust Strategic Award (WT104033AIA)
- The Muir Maxwell Trust
- The Amelia Roberts Fellowship
- The Fidelity Foundation
- Dravet syndrome UK
- The Wellcome Trust, Cancer Research UK
- Medical Research Council
- National Institute for Health Research
- University College London Hospitals Biomedical Research Centre
- UK Department of Health’s NIHR Biomedical Research Centres
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- Dravet syndrome, SCN1A, loss-of-function mutations, phenotypic heterogeneity, rare variants, DEPDC5, focal cortical dysplasia, polygenic risk score, intelligence, longevity, premature mortality
- MeSH terms
- Epilepsy, Epilepsies, Myoclonic, Humans, Phenotype, Genomics, NAV1.1 Voltage-Gated Sodium Channel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.